文献速递乳腺癌放疗放疗物理与技术

早期乳腺癌辅助放疗后冠心病风险:丹麦29,662例人群研究

Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study.
PubMed 文献 · Radiother Oncol · 2021-01-27

该研究基于丹麦人群登记数据,纳入1999-2016年诊断的29,662例早期乳腺癌患者,其中22,056例接受放疗,比较非CT定位期(1999-2007)与CT定位期(2008-2016)左侧与右侧乳腺癌放疗后心脏事件风险。非CT定位期左侧患者心脏事件发生率比为1.44(95%CI 1.07-1.94),CT定位期该比为0.90(95%CI 0.69-1.16),提示CT定位放疗后10年内左侧与右侧患者心脏事件风险无差异。

要点

  • 非CT定位期左侧乳腺癌放疗后心脏事件风险显著高于右侧(IRR 1.44)。
  • CT定位期左侧与右侧患者心脏事件风险无显著差异(IRR 0.90)。
  • CT定位期10年内心脏事件风险无左侧劣势趋势。

核心结论

  • 非CT定位期左侧乳腺癌放疗患者心脏事件风险高于右侧患者。
  • CT定位期左侧与右侧患者放疗后10年内心脏事件风险无差异,但10年后数据有限。

研究设计与样本

  • 基于丹麦人群医学登记数据的队列研究,纳入1999-2016年诊断的早期乳腺癌患者29,662例,其中22,056例接受放疗。
  • 按非CT定位期(1999-2007)与CT定位期(2008-2016)分层,比较左侧与右侧乳腺癌患者心脏事件风险。
  • 心脏事件定义为冠状动脉疾病或严重瓣膜性心脏病。

主要发现

  • 非CT定位期放疗患者10年心脏事件累积风险为1.7%(95%CI 1.4-2.0),中位随访11.1年。
  • 非CT定位期左侧与右侧患者心脏事件发生率比为1.44(95%CI 1.07-1.94)。
  • CT定位期放疗患者10年心脏事件累积风险为2.1%(95%CI 1.8-2.4),中位随访6.8年。
  • CT定位期左侧与右侧患者心脏事件发生率比为0.90(95%CI 0.69-1.16),10年内未见左侧劣势趋势。

临床怎么用

  • 采用CT定位放疗规划可能降低左侧乳腺癌患者放疗后心脏事件风险。
  • 对左侧乳腺癌放疗患者,CT定位下心脏剂量评估有助于减少心脏事件。

局限性

  • CT定位期随访中位6.8年,放疗后10年以上心脏事件信息有限。
  • 心脏事件定义限于冠状动脉疾病或严重瓣膜性心脏病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiotherapy (RT) for early breast cancer (BC) reduces the risk of recurrence and improves overall survival. However, thoracic RT may cause some incidental RT dose to the heart with subsequent risk of heart disease. During 2000-2010, CT-based RT planning was gradually introduced. The aim of this study was to investigate the risk of cardiac events in left-sided compared with right-sided BC patients treated during a non-CT-based (1999-2007) vs a CT-based period (2008-2016). MATERIAL AND METHODS: Information on BC and cardiac events among Danish women was obtained from population-based medical registers. Patients diagnosed with BC during 1999-2016, were included. A cardiac event was defined as coronary artery disease or severe valvular heart disease. RESULTS: Among 29,662 patients, 22,056 received RT. For those irradiated during the non-CT-based period, the 10-year cumulative risk of cardiac event was 1.7% (95% CI 1.4-2.0) at median follow-up of 11.1 years. The incidence rate ratio (IRR) for cardiac event in left-sided vs right-sided patients was 1.44 (1.07-1.94) and a trend towards worse outcome was seen within the first 10 years after RT and approached statistical significance with longer follow-up. Among patients irradiated during the CT-based period, the 10-year cumulative risk of cardiac event was 2.1% (1.8-2.4) at median 6.8 years follow-up. The IRR for cardiac event in left-sided vs right-sided patients was 0.90 (0.69-1.16) and no trend towards worse outcome within the first 10 years was observed. CONCLUSION: This study confirmed a higher risk of cardiac events in left-sided vs right-sided BC patients irradiated during a non-CT-based period. For patients irradiated during a CT-based period, no increased risk of cardiac events in left-sided vs right-sided patients was observed within the first 10 years after RT, whilst information on cardiac events beyond 10 years after RT was limited.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Milo MLH, Thorsen LBJ, Johnsen SP, et al. Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study. Radiother Oncol. 2021. PMID: 33515670. doi:10.1016/j.radonc.2021.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。